Company Profile
About Eli Lilly & Co. (LLY)
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Sector
PHARMACEUTICAL PREPARATIONS
Market Cap
$1.01T
Employees
50,000
Headquarters
INDIANAPOLIS, IN
Website
Latest Trading Data
Previous Close
$1208.12
Open
$1128.80
Day Range
$1128.00 - $1215.76
Volume
7,725,847